ResMed, Inc. (RMD) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $220.05 +3.83%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
SIF, GLXZ, ALTI, More
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
SIF, GLXZ, ALTI, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $397.8 million versus the consensus estimate of $401 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Helios Technologies (HLIO) Tops Q2 EPS by 8c; raises guidance
- BridgeBio Pharma Inc. (BBIO) Misses Q2 EPS by 18c
- Hims & Hers Health, Inc. (HIMS) Misses Q2 EPS by 32c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
